XML 60 R46.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Significant Accounting Policies - Schedule of Company's Revenue by Type (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
[1]
Mar. 31, 2018
[1]
Dec. 31, 2017
[1]
Sep. 30, 2017
[1]
Jun. 30, 2019
Jun. 30, 2018
[2]
Jun. 30, 2017
[2]
Disaggregation Of Revenue [Line Items]                      
Total revenue $ 215.4 $ 216.6 $ 216.8 $ 202.3 $ 193.9 $ 183.1 $ 187.9 $ 178.8 $ 851.1 $ 743.7 [1] $ 728.7 [1]
Molecular Diagnostic - Hereditary Cancer Testing [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 479.7 471.4 525.5
Molecular Diagnostic - GeneSight [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 112.6 124.9 78.4
Molecular Diagnostic - Prenatal [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 104.9    
Molecular Diagnostic- Vectra [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 48.3 55.2 45.2
Molecular Diagnostic - Prolaris [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 25.5 21.5 11.1
Molecular Diagnostic - EndoPredict [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 10.4 8.8 7.7
Molecular Diagnostic - Other [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 8.0 8.6 11.5
Molecular Diagnostic Testing [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue 196.9 200.5 203.0 189.0 180.6 169.3 173.1 167.4 789.4 690.4 [1] 679.4 [1]
Pharmaceutical and Clinical Services [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue $ 18.5 $ 16.1 $ 13.8 $ 13.3 $ 13.3 $ 13.8 $ 14.8 $ 11.4 $ 61.7 $ 53.3 [1] $ 49.3 [1]
[1] Amounts adjusted due to the adoption of Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). See Note 1 to the financial statements of this report for additional information.
[2] Amounts adjusted due to the adoption of Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606)